http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103626817-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 |
| filingDate | 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103626817-B |
| titleOfInvention | Androstane-3 β, 5 α, crystal-form compound of 6 beta-triols and preparation method thereof |
| abstract | The invention discloses androstane-3 β, 5 α, four kinds of crystal-form compound (A crystal formation YC-6, B crystal form YC-6, C crystal form YC-6, form D YC-6) of 6 beta-triols (being called for short YC-6) and preparation method thereof.The characteristic of four kinds of crystal-form compound is that their unit cell parameters, 2 θ of X-ray powder diffraction and the parameter such as intensity, fusing point exist significant difference, studies its polymorphism to research its drug effect, bioavailability and stability is significant further. |
| priorityDate | 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.